Pharmacokinetics and dosage adjustment in patients with renal dysfunction

Area of Science:

• Pharmacology
• Nephrology
• Drug Development

Background:

• Chronic kidney disease (CKD) is a growing global health concern.
• Renal dysfunction impairs drug excretion and metabolism, leading to accumulation and potential toxicity.
• Reduced plasma protein binding in CKD affects drug distribution and elimination.

Purpose of the Study:

• To highlight the impact of renal dysfunction on drug pharmacokinetics.
• To emphasize the need for appropriate drug dosage adjustments in patients with kidney disease.
• To discuss the challenges and methodologies in assessing drug behavior in renal impairment.

Main Methods:

• Review of pharmacokinetic alterations in chronic renal failure.
• Discussion of dosage adjustment strategies based on estimated glomerular filtration rate (GFR).
• Mention of regulatory guidelines for drug development in renally impaired populations.

Main Results:

• Renal dysfunction affects drug handling beyond renal excretion, impacting metabolism and protein binding.
• Standard dosage adjustments may not prevent adverse drug reactions.
• Dialysis can remove drugs, requiring specific considerations for end-stage renal disease patients.

Conclusions:

• Drug pharmacokinetics are significantly altered in patients with renal dysfunction.
• Dosage adjustments are crucial but may not fully mitigate risks.
• Pharmacokinetic studies during drug development are essential for drugs used in renally impaired patients.